Two months after saying it couldn't recommend Genmab's cervical cancer therapy Tivdak for use by the NHS, reimbursement ...

An unsolicited bid by private equity group CVC to take control of Italian pharma company Recordati looks likely to come off, ...

Biogen and Denali have now confirmed that the results show BIIB122 (also known as DNL151) did not slow the progression of ...

Merck, known as MSD outside the United States and Canada announced that the Food and Drug Administration (FDA) has approved two new HIV-1 medicines: Delstrigo and Pifeltro. The FDA has approved ...

Eli Lilly's triple G agonist retatrutide has achieved weight loss of more than 28% in a new phase 3 trial that keeps it on course for regulatory filings later this year. The readout from the TRIUMPH-1 ...

Pfizer has upped the ante in the increasingly competitive market for pneumococcal vaccines with mid-stage clinical data for a ...

Bayer has filed to modify the label for its chronic kidney disease (CKD) Kerendia to include people with type 1 diabetes, ...

Alector abandoned development of latozinemab as a treatment for frontotemporal dementia (FTD) after it failed a phase 3 trial, and will turn its attention to a midstage Alzheimer's programme. The ...

A US district court has granted an injunction sought by Incyte on the launch of Sun Pharma's recently approved Leqselvi for alopecia areata. In a brief filing with the National Stock Exchange (NSE) of ...

There is only one approved therapy for lung disease non-cystic fibrosis bronchiectasis (NCFB) in the US and Europe – Insmed's ...

The Singapore Court of Appeal has retained an injunction against KBP Bio and its founder, Dr Huang Zhenhua, and ruled that a lawsuit brought by Novo Nordisk will be taken to arbitration. Last year, ...

A 'hybrid' therapy for Parkinson's disease developed by Remepy, combining a drug with a digital therapeutic, has shown ...